Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities HALO - Halozyme Therapeutics, Inc.
-219 M
LAST VALUE
-26.65%
2 YEAR CAGR
-19.42%
5 YEAR CAGR
-11.28%
10 YEAR CAGR